Related Experiment Video
Updated: Dec 23, 2025

Novel Diagnostics in Revision Arthroplasty: Implant Sonication and Multiplex Polymerase Chain Reaction
Published on: December 3, 2017
Circulating D-Dimer versus Fibrinogen in the Diagnosis of Peri-Prosthetic Joint Infection: A Meta-Analysis
Qingyu Zhang1, Jinlei Dong1, Dongsheng Zhou1
1Department of Orthopaedics, Shandong Provincial Hospital affiliated to Shandong University, Shandong, China.
Abstract:
Circulating D-dimer and fibrinogen are both emerging as promising biomarkers for the diagnosis of peri-prosthetic joint infection (PJI), but their clinical values still remain disputable. This study aims to evaluate and compare the accuracy of circulating D-dimer and fibrinogen in the diagnosis of suspected PJI. We conducted a comprehensive literature search in PubMed, EMBASE, and the Cochrane Library to retrieve diagnostic accuracy studies in which PJI was investigated with circulating D-dimer or fibrinogen from the time of database inception to August 1, 2019. The pooled sensitivity, specificity, likelihood ratios and diagnostic odds ratio (DOR), summary receiver operating characteristic (sROC) curves, and area under the sROC curve (AUC) were constructed using a meta-analysis framework. Seven eligible studies (1,374 patients) were included in the quantitative analysis. The mean levels of circulating D-dimer and fibrinogen were all significantly higher in patients with PJI. The plasma fibrinogen illustrated relatively higher sensitivity (0.84, 95% confidence interval [CI]: 0.78-0.98) and specificity (0.80, 95% CI: 0.76-0.84) than circulating D-dimer (0.74, 95% CI: 0.69-0.78; 0.66, 95% CI: 0.62-0.69, respectively) for the diagnosis of PJI. The pooled DOR of D-dimer, fibrinogen, erythrocyte sedimentation rate (ESR), and C-reactive protein (CRP) to diagnose PJI was 7.00 (95% CI, 2.50-19.59), 12.40 (95% CI, 5.85 to 26.28), 10.71 (95% CI, 7.76 to 14.78) and 16.22 (95% CI 11.71-22.46), respectively, while the pooled AUC was 0.84 (95% CI, 0.77-0.90), 0.87 (95% CI, 0.85-0.89), 0.82 (95% CI, 0.78-0.85) and 0.87 (95% CI, 0.86-0.88), respectively. This meta-analysis reveals that it could be concluded that plasma fibrinogen is an excellent biomarker for diagnosing PJI, comparable to serum CRP and ESR, while the diagnostic value of circulating D-dimer is only moderate. Large-scale, prospective studies are still needed to confirm current findings.
Insights
Plasma fibrinogen is an excellent biomarker for diagnosing peri-prosthetic joint infection (PJI), comparable to CRP and ESR. Circulating D-dimer shows only moderate diagnostic value for PJI, requiring further large-scale studies.
Area of Science:
- Orthopedics
- Biomarkers
- Diagnostic Accuracy
Background:
- Peri-prosthetic joint infection (PJI) diagnosis relies on various biomarkers.
- Circulating D-dimer and fibrinogen are emerging as potential diagnostic markers for PJI.
- Their comparative clinical utility remains under investigation.
Purpose of the Study:
- To evaluate and compare the diagnostic accuracy of circulating D-dimer and fibrinogen for suspected PJI.
- To synthesize existing evidence through a meta-analysis.
Main Methods:
- Comprehensive literature search in PubMed, EMBASE, and Cochrane Library up to August 1, 2019.
- Inclusion of diagnostic accuracy studies investigating D-dimer or fibrinogen in PJI.
- Meta-analysis to calculate pooled sensitivity, specificity, diagnostic odds ratio (DOR), and area under the summary receiver operating characteristic curve (AUC).
Main Results:
- Seven studies with 1,374 patients were included.
- Both D-dimer and fibrinogen levels were significantly higher in PJI patients.
- Plasma fibrinogen demonstrated higher sensitivity (0.84) and specificity (0.80) than D-dimer (sensitivity 0.74, specificity 0.66).
- Pooled AUC for fibrinogen (0.87) and CRP (0.87) were higher than for D-dimer (0.84) and ESR (0.82).
Conclusions:
- Plasma fibrinogen is an excellent biomarker for PJI diagnosis, comparable to CRP and ESR.
- Circulating D-dimer has a moderate diagnostic value for PJI.
- Further large-scale, prospective studies are warranted to validate these findings.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Anticoagulant Drugs: Low-Molecular-Weight Heparins

